Word

Status

Registered

Status Code

700

Status Date

Tuesday, January 29, 2019

Serial Number

79230374

Registration Number

5663613

Registration Date

Tuesday, January 29, 2019

Mark Type

2000

Filing Date

Thursday, March 30, 2017

Published for Opposition

Tuesday, November 13, 2018

Trademark Owner History

Mapix S.à.r.l. - Original Registrant

Classifications

5 Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical antitussive-cold preparations, preparations for treating colds and flu, preparations for preventing colds and flu, preparations for relief of cold and flu symptoms such as nasal congestion, cough and fever, and preparations for shortening the durations of colds and flu; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical use and veterinary use; food for babies; dietary supplements for humans and animals; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, and adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, and espiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based drugs pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; Pharmaceutical preparations, namely, immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infectious diseases

The mark consists of the following: a stylized drawing of a penguin having a blue body, head and wings with a white chest and face. The eyes are blue and white and the beak is orange with a white section and the feet are orange. The penguin wears an orange scarf outlined in the color dark blue, as are the feet. The overall background is white.
The color(s) blue, dark blue, orange and white is/are claimed as a feature of the mark.

Trademark Events

Jan 29, 2024

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Jun 7, 2019

Final Decision Transaction Processed By Ib

May 21, 2019

Final Disposition Notice Sent To Ib

May 21, 2019

Final Disposition Processed

Apr 29, 2019

Final Disposition Notice Created, To Be Sent To Ib

Jan 29, 2019

Registered-Principal Register

Nov 13, 2018

Official Gazette Publication Confirmation E-Mailed

Nov 13, 2018

Published For Opposition

Nov 9, 2018

Notification Processed By Ib

Oct 24, 2018

Notification Of Possible Opposition Sent To Ib

Oct 24, 2018

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Oct 24, 2018

Notification Of Notice Of Publication E-Mailed

Sep 26, 2018

Approved For Pub - Principal Register

Sep 12, 2018

Teas/Email Correspondence Entered

Sep 11, 2018

Correspondence Received In Law Office

Sep 11, 2018

Teas Response To Office Action Received

Sep 11, 2018

Teas Change Of Correspondence Received

Jun 7, 2018

Change Of Name/Address Rec'd From Ib

May 25, 2018

Refusal Processed By Ib

May 3, 2018

Non-Final Action Mailed - Refusal Sent To Ib

May 3, 2018

Refusal Processed By Mpu

Apr 28, 2018

Non-Final Action (Ib Refusal) Prepared For Review

Apr 27, 2018

Non-Final Action Written

Apr 24, 2018

Application Filing Receipt Mailed

Apr 20, 2018

Assigned To Examiner

Apr 20, 2018

New Application Office Supplied Data Entered

Apr 19, 2018

Sn Assigned For Sect 66a Appl From Ib